Risk of Adverse Neurocognitive Outcomes With PCSK-9 Inhibitors

Jeffrey W. Meeusen; Leslie J. Donato; Allan S. Jaffe

doi:10.1016/j.jacc.2017.03.583

Risk of Adverse Neurocognitive Outcomes With PCSK-9 Inhibitors

Jeffrey W. Meeusen, Leslie J. Donato, Allan S. Jaffe

Cardiovascular Medicine

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	2774-2775
Number of pages	2
Journal	Journal of the American College of Cardiology
Volume	69
Issue number	22
DOIs	https://doi.org/10.1016/j.jacc.2017.03.583
State	Published - Jun 6 2017

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2017.03.583

Cite this

@article{580b9bdb0f684dfca9f15c39627182bb,

title = "Risk of Adverse Neurocognitive Outcomes With PCSK-9 Inhibitors",

author = "Meeusen, {Jeffrey W.} and Donato, {Leslie J.} and Jaffe, {Allan S.}",

year = "2017",

month = jun,

day = "6",

doi = "10.1016/j.jacc.2017.03.583",

language = "English (US)",

volume = "69",

pages = "2774--2775",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "22",

}

TY - JOUR

T1 - Risk of Adverse Neurocognitive Outcomes With PCSK-9 Inhibitors

AU - Meeusen, Jeffrey W.

AU - Donato, Leslie J.

AU - Jaffe, Allan S.

PY - 2017/6/6

Y1 - 2017/6/6

UR - http://www.scopus.com/inward/record.url?scp=85019657442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019657442&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2017.03.583

DO - 10.1016/j.jacc.2017.03.583

M3 - Letter

C2 - 28571647

AN - SCOPUS:85019657442

SN - 0735-1097

VL - 69

SP - 2774

EP - 2775

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 22

ER -

Risk of Adverse Neurocognitive Outcomes With PCSK-9 Inhibitors

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this